• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

逆转录病毒基因转导入由白细胞介素-2和表达膜结合型白细胞介素-21的K562饲养细胞激活的原代人自然杀伤细胞。

Retroviral gene transfer into primary human NK cells activated by IL-2 and K562 feeder cells expressing membrane-bound IL-21.

作者信息

Streltsova Maria A, Barsov Eugene, Erokhina Sofia A, Kovalenko Elena I

机构信息

Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya, Moscow 117997, Russia.

Cell Design Labs, Inc., Emeryville, CA, USA.

出版信息

J Immunol Methods. 2017 Nov;450:90-94. doi: 10.1016/j.jim.2017.08.003. Epub 2017 Aug 10.

DOI:10.1016/j.jim.2017.08.003
PMID:28802832
Abstract

Natural killer (NK) cells are capable of rapidly recognizing and efficiently killing tumor cells. This makes them a potentially promising agent for cancer immunotherapy. Additional genetic modifications of NK cells may further improve their anti-tumor efficacy. Numerous technical challenges associated with gene delivery into NK cells have significantly tempered this approach. We achieved efficient retroviral vector transduction of primary human NK cells that were stimulated by a combination of IL-2 and engineered K562 cells expressing membrane-bound IL-21. The activated NK cells were in less differentiated state and expressed NK cell activation receptors NKG2D, NKp30, CD16, and were highly HLA-DR-positive. This NK cell population was highly susceptible to the transduction by both GFP- and NGFR-expressing retroviral vectors, with transduction efficiency exceeding 50%. More mature CD57 NK cell population was generally resistant to retroviral vector transduction because of poor response to the stimulation. Our findings may facilitate retroviral vector-mediated genetic engineering of human primary NK cells for future immunotherapies.

摘要

自然杀伤(NK)细胞能够快速识别并有效杀伤肿瘤细胞。这使其成为癌症免疫治疗中一种潜在的有前景的药物。对NK细胞进行额外的基因改造可能会进一步提高其抗肿瘤功效。然而,与将基因导入NK细胞相关的众多技术挑战显著限制了这种方法的应用。我们通过白细胞介素-2(IL-2)与表达膜结合型IL-21的工程化K562细胞联合刺激,实现了对原代人NK细胞的高效逆转录病毒载体转导。活化的NK细胞处于较低分化状态,表达NK细胞活化受体NKG2D、NKp30、CD16,且高度表达HLA-DR。这群NK细胞对表达绿色荧光蛋白(GFP)和神经生长因子受体(NGFR)的逆转录病毒载体转导高度敏感,转导效率超过50%。由于对刺激反应不佳,更成熟的CD57 NK细胞群体通常对逆转录病毒载体转导具有抗性。我们的研究结果可能有助于通过逆转录病毒载体介导对人原代NK细胞进行基因工程改造,以用于未来的免疫治疗。

相似文献

1
Retroviral gene transfer into primary human NK cells activated by IL-2 and K562 feeder cells expressing membrane-bound IL-21.逆转录病毒基因转导入由白细胞介素-2和表达膜结合型白细胞介素-21的K562饲养细胞激活的原代人自然杀伤细胞。
J Immunol Methods. 2017 Nov;450:90-94. doi: 10.1016/j.jim.2017.08.003. Epub 2017 Aug 10.
2
Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.人自然杀伤细胞制备的优化:全自动分离,使用 IL-21 和自体饲养细胞进行体外扩增的改进,以及生成表达抗 CD123-CAR 的效应细胞。
Hum Gene Ther. 2017 Oct;28(10):897-913. doi: 10.1089/hum.2017.157. Epub 2017 Aug 15.
3
Recurrent Stimulation of Natural Killer Cell Clones with K562 Expressing Membrane-Bound Interleukin-21 Affects Their Phenotype, Interferon-γ Production, and Lifespan.用表达膜结合白细胞介素-21 的 K562 细胞反复刺激自然杀伤细胞克隆会影响其表型、干扰素-γ产生和寿命。
Int J Mol Sci. 2019 Jan 21;20(2):443. doi: 10.3390/ijms20020443.
4
HLA-DR NK cells are mostly characterized by less mature phenotype and high functional activity.HLA-DR NK 细胞的表型大多不成熟,功能活性高。
Immunol Cell Biol. 2018 Feb;96(2):212-228. doi: 10.1111/imcb.1032. Epub 2017 Dec 19.
5
NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation.来自恶性胸腔积液的 NK 细胞不是无反应性的,但在短期 IL-2 激活下产生细胞因子并显示出强大的抗肿瘤活性。
Eur J Immunol. 2013 Feb;43(2):550-61. doi: 10.1002/eji.201242783. Epub 2013 Jan 15.
6
Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of "senescent" NK cells to lose CD57 expression and start expressing NKG2A.使用白细胞介素 2 和基因修饰的 K562 细胞获得的 NK 细胞克隆分析表明,“衰老”NK 细胞丧失 CD57 表达并开始表达 NKG2A 的能力。
PLoS One. 2018 Dec 5;13(12):e0208469. doi: 10.1371/journal.pone.0208469. eCollection 2018.
7
Gene Modification of Human Natural Killer Cells Using a Retroviral Vector.使用逆转录病毒载体对人自然杀伤细胞进行基因修饰。
Methods Mol Biol. 2016;1441:203-13. doi: 10.1007/978-1-4939-3684-7_17.
8
Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21.利用表达 OX40L 的 K562 细胞和短时间暴露于 IL-21 扩增人自然杀伤细胞。
Front Immunol. 2019 Apr 24;10:879. doi: 10.3389/fimmu.2019.00879. eCollection 2019.
9
Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21.工程化 K562 细胞共表达 4-1BBL 和 mMICA 联合可溶性 IL-21 扩增 NK 细胞。
Cell Immunol. 2014 Jul;290(1):10-20. doi: 10.1016/j.cellimm.2014.04.011. Epub 2014 May 2.
10
Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21.用表达 OX40L 和膜结合型 IL-18、IL-21 的 K562 细胞扩增多发性骨髓瘤患者的细胞毒性自然杀伤细胞。
Cancer Immunol Immunother. 2022 Mar;71(3):613-625. doi: 10.1007/s00262-021-02982-9. Epub 2021 Jul 20.

引用本文的文献

1
Recent advances in tumor immunotherapy based on NK cells.基于自然杀伤细胞的肿瘤免疫疗法的最新进展。
Front Immunol. 2025 Aug 7;16:1595533. doi: 10.3389/fimmu.2025.1595533. eCollection 2025.
2
Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editing.通过非病毒工程和高度多重碱基编辑提高CAR-NK细胞的精准度。
J Immunother Cancer. 2025 May 7;13(5):e009560. doi: 10.1136/jitc-2024-009560.
3
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors.嵌合抗原受体 T 细胞(CAR-T)和嵌合抗原受体自然杀伤细胞(CAR-NK)作为实体瘤的细胞癌症免疫疗法。
Cell Mol Immunol. 2024 Oct;21(10):1089-1108. doi: 10.1038/s41423-024-01207-0. Epub 2024 Aug 12.
4
The hTERT and iCasp9 Transgenes Affect EOMES and T-BET Levels in NK Cells and the Introduction of Both Genes Improves NK Cell Proliferation in Response to IL2 and IL15 Stimulation.hTERT和iCasp9转基因影响NK细胞中EOMES和T-BET水平,同时导入这两个基因可改善NK细胞对IL2和IL15刺激的增殖反应。
Biomedicines. 2024 Mar 14;12(3):650. doi: 10.3390/biomedicines12030650.
5
Precision Enhancement of CAR-NK Cells through Non-Viral Engineering and Highly Multiplexed Base Editing.通过非病毒工程和高度多重碱基编辑提高CAR-NK细胞的精准度
bioRxiv. 2024 Mar 8:2024.03.05.582637. doi: 10.1101/2024.03.05.582637.
6
The Progress and Prospects of Immune Cell Therapy for the Treatment of Cancer.免疫细胞疗法治疗癌症的进展与前景
Cell Transplant. 2024 Jan-Dec;33:9636897241231892. doi: 10.1177/09636897241231892.
7
Obtaining Gene-Modified HLA-E-Expressing Feeder Cells for Stimulation of Natural Killer Cells.获取用于刺激自然杀伤细胞的基因修饰的HLA-E表达饲养细胞。
Pharmaceutics. 2024 Jan 19;16(1):133. doi: 10.3390/pharmaceutics16010133.
8
Chimeric antigen receptor engineered natural killer cells for cancer therapy.用于癌症治疗的嵌合抗原受体工程化自然杀伤细胞。
Exp Hematol Oncol. 2023 Aug 10;12(1):70. doi: 10.1186/s40164-023-00431-0.
9
Chimeric antigen receptor-natural killer cells: a promising sword against insidious tumor cells.嵌合抗原受体自然杀伤细胞:对抗隐匿性肿瘤细胞的一把利剑。
Hum Cell. 2023 Nov;36(6):1843-1864. doi: 10.1007/s13577-023-00948-w. Epub 2023 Jul 21.
10
Case report: Long-term voluntary Tyrosine Kinase Inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML): Molecular evidence of an immune surveillance.病例报告:慢性髓性白血病(CML)中酪氨酸激酶抑制剂(TKI)的长期自愿停药:免疫监视的分子证据
Front Oncol. 2023 Mar 16;13:1117781. doi: 10.3389/fonc.2023.1117781. eCollection 2023.